About the Startup
A personalized medicine company specializing in genetic and epigenetic analyses to integrate genomics-based diagnostics into medical practice (polygenic risk analyses, pharmacogenetic tests, epigenetic age assessments).
Source: https://brutkasten.com/artikel/permedio-haselsteiner-steigt-als-investor-bei-schneider-startup-ein
Frequently Asked Questions
What type of funding round did Permedio raise?
Permedio raised a unspecified round.
When did Permedio raise its unspecified?
Permedio raised its unspecified on 2026-01-08.
Who invested in Permedio's unspecified?
The investors in Permedio's unspecified are: Hans Peter Haselsteiner (via ZMH GmbH).
What type of investment was Permedio's unspecified?
Permedio's unspecified was a equity investment.